Melissa V. Rewolinski, PhD

Melissa V. Rewolinski, PhD

DirectoratArbutus Biopharma· In proxies 2023–2025

Melissa V. Rewolinski, PhD sits on 1 public board.

Experience

  1. Arbutus BiopharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +85%
  2. Lannett Company, Inc.Public company · 4 yr
    • Director2019 – 2023 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?